Stock Upgrades Today

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  09 Jan 2026
 

•   AAPL  
   
  +0.15%
•   ABNB  
   
  +0.05%
•   ALLY  
   
  -0.04%
•   AMKR  
   
  -0.02%
•   APLD  
   
  0.00%

$AAPL continues to capture investor attention as Bernstein reiterates its Buy rating with a $325 price target. The stock resilience in the $259 range reflects strong consumer demand for iPhones, services growth, and investor confidence in its ecosystem. Despite minimal intraday movement, heavy volume of nearly 40 million shares shows consistent institutional interest. For long-term investors, Apple remains a core tech play with robust margins and recurring revenue streams.

$ABNB received an upgrade from Barclays as the combination of RNPL hotel expansion and World Cup-driven travel demand boosts near-term revenue prospects. Trading around $139, volume slightly above average indicates growing attention from analysts and traders anticipating a surge in bookings and margin expansion. Airbnb diversified business model and global footprint support upside potential amid macro travel trends.

$ALLY caught the spotlight with UBS initiating coverage at a Buy rating. With shares at $45.72, the implied upside of over 10% reflects confidence in Ally Financial loan portfolio and credit quality amid a rising interest rate environment. Although the stock experienced a minor pullback intraday, the broader trend suggests solid positioning in the financial services sector with stable returns and strong regulatory compliance.

$AMKR surged after Needham raised its price target to $50, citing explosive CoWoS wafer demand driven by AI growth. Shares at $52.29 gained more than 2.5% as traders reacted to the increasing adoption of AI chips, which directly drives Amkor revenue. The semiconductor packaging and test space is seeing structural growth, positioning AMKR as a critical supplier in AI hardware supply chains, and supporting both revenue visibility and margin expansion.

$APLD grabbed attention with Arete Research initiating coverage with a $99 price target and Buy rating. Shares jumped nearly 18% on massive volume, reflecting optimism about Applied Digital role in data centers and AI infrastructure. The sharp move indicates strong market appetite for tech companies benefitting from the AI and cloud computing revolution, though investors should monitor execution risk and competitive pressures in this fast-moving sector.

$APP remains on analysts’ radar with Benchmark reiterating a Buy rating and $775 price target. Trading near $647, the stock reflects enthusiasm around its mobile ad platform, strong user engagement metrics, and persistent growth in app monetization. High volume relative to average suggests investors are positioning ahead of expected earnings beats and continued expansion into international markets.

$ARBE saw a strong reaction to WestPark Capital initiating coverage with a Buy rating and nearly 50% upside potential. Shares around $1.36 rallied more than 7%, signaling enthusiasm for Arbe Robotics’ radar technology in autonomous vehicles and industrial applications. The unique IP and early-mover advantages could translate into meaningful contracts as adoption in smart mobility grows.

$AVGO attracted attention after Goldman Sachs added Broadcom to its US Conviction List, maintaining a Buy rating at a $450 price target. Shares trading near $345 reflect optimism around diversified semiconductor and networking products, strong recurring revenue, and exposure to enterprise AI adoption. Analyst upgrades underscore confidence in Broadcom strategic positioning despite broader market volatility.

$BCAX benefited from BTIG initiating coverage with a Buy rating and an implied 100% upside. At $17.95, the strong relative volume suggests early institutional accumulation in this small-cap biotech, highlighting expectations for clinical or regulatory milestones that could trigger a meaningful revaluation.

$BFH was upgraded by UBS, though the stock faces a slight downside risk of 9% per the analyst forecast. Trading at $80.36, the upgrade reflects confidence in Bread Financial loan origination and servicing business, though near-term credit quality and interest rate sensitivity remain key factors for investors.

$CIEN continues to draw attention with Argus upgrading its outlook amid a record $5B backlog and strong AI networking demand. Shares near $230 are supported by expanding enterprise and data center adoption of next-gen networking solutions. The surge in orders illustrates both robust growth and investor confidence in Ciena ability to capitalize on AI infrastructure trends.

$CLF gained momentum on a Cleveland-Cliffs upgrade, reflecting optimism around steel demand recovery and cost-efficient operations. Trading around $12.76, shares benefited from positive sentiment across industrials as infrastructure spending and commodity pricing support margins and cash flow generation.

$COF received multiple analyst upgrades, including a price target lift to $300 by Goldman Sachs. At $249.20, Capital One Financial continues to show strong credit portfolio performance and digital banking adoption, but the stock remains sensitive to interest rate shifts and credit quality trends.

$CORT saw a moderate rebound after Canaccord Genuity lowered the price target but maintained a Buy rating. At $37.50, investor interest is supported by long-term pipeline potential, although FDA correspondence introduces near-term regulatory uncertainty.

$CROX upgraded to Mixed by BWG Global, reflecting 7% upside potential. Trading near $86, investor sentiment is cautiously positive amid stable retail trends, brand positioning, and renewed consumer demand.

$CRWD rose following Berenberg Buy upgrade after a recent pullback. Trading near $470, CrowdStrike continues to benefit from strong cybersecurity tailwinds, subscription-based revenue growth, and expanded enterprise adoption.

$DAL received a double upgrade with shares trading near $72.31. Airline sector momentum, fueled by strong bookings and operational efficiency, underpins bullish sentiment ahead of upcoming earnings.

$DINO outlook improved to Overweight by Piper Sandler, reflecting optimism on energy markets and HF Sinclair operational performance. Shares at $50.30 now show potential upside approaching 21%, supported by refining margin expansion and oil demand trends.

$EHAB upgraded by UBS, though near-term downside remains minimal. Trading at $9.97, the stock growth story is modest, with upside tied to residential energy solutions adoption.

$FANG continues to face pressure despite holding a Buy rating. At $147.41, energy market volatility and production challenges are key factors influencing investor sentiment.

$FTRE upgraded to Buy by Truist, signaling 23% downside potential from current levels near $17.39, reflecting market caution despite strategic positioning in tech-enabled industrial services.

$GAP saw an upgrade from UBS with minor upside. Trading near $28.32, retail positioning and consumer discretionary trends will dictate performance near term.

$GOOG received a Cantor Fitzgerald upgrade to Overweight. At $329.15, Alphabet diversified business model, AI initiatives, and ad platform growth continue to make it a strategic long-term holding despite a modest near-term downside forecast.

$KARO upgraded for profitable revenue growth, trading at $45.59. Investor confidence is driven by consistent revenue gains and market expansion.

$LASR highlighted for strategic advantage in directed energy lasers, trading near $40. While niche, the stock benefits from defense and tech sector tailwinds.

$LLY upgraded by UBS, with shares near $1063. Leadership in obesity treatment and oncology pipelines positions Eli Lilly as a long-term growth story, though short-term volatility could emerge from drug approvals or regulatory news.

$LMT upgraded to Buy by Truist. At $542.92, Lockheed Martin benefits from strong defense budgets and global program execution, making it attractive for investors focused on stable cash flows and dividend growth.

$LPTH raised by Lake Street to $14 price target, trading at $12.34. The drone optics backlog and expansion into commercial applications support medium-term growth expectations.

$LUV received a double upgrade from JPMorgan, pushing shares near $44.52 as airline sector momentum continues to drive optimism, supported by capacity management and cost controls.

$MARA remains under pressure despite prior Buy ratings, with Bitcoin-linked volatility creating headwinds at $10.22. Investors should be cautious given crypto market dependency.

$MDB raised by Truist to a $500 price target, trading near $408. Strong AI adoption and subscription-based software revenue support the upgrade, making MongoDB an attractive growth tech pick.

$META upgraded via long-term energy collaboration, trading at $653.06. Partnerships in nuclear energy support sustainability initiatives and operational efficiency, signaling strategic positioning beyond core ad business.

$MRK upgraded by Wolfe Research to Outperform, with shares near $110.53. Pharmaceutical stability, pipeline execution, and dividend reliability appeal to conservative investors.

$NVDA maintained Buy by Citi, trading at $184.83. Leadership in AI chips and GPU adoption supports secular growth, though valuation and sector volatility should be monitored closely.

$PALI initiated Buy by B. Riley, trading near $1.99. Small-cap biotech upside is speculative, dependent on pipeline progress.

$PII upgraded by Seaport Global, trading at $71.90. Energy sector performance and integrated solutions provide moderate upside potential.

$RARE maintains Buy rating despite reduced target, trading at $22.51. Upside exists from pipeline execution, though market reaction may remain muted.

$RBRK upgraded reflecting strong enterprise software positioning, shares near $70.56. Outperformance potential is tied to market share gains and SaaS adoption.

$ROKU upgraded by Evercore ISI, trading at $111.17. Streaming ad growth and platform expansion underpin the positive analyst outlook.

$SLNO reaffirmed Buy rating, trading at $43. Soleno biotech pipeline suggests medium-term upside, though volatility remains elevated.

$SNOW upgraded by Argus to Buy, trading at $219.09. Snowflake benefits from cloud adoption and recurring revenue, making it a growth tech play worth monitoring.

$SPRY surged after China approval and competitor setback, trading at $13.06. Regulatory wins and market expansion make this biotech one of the more compelling near-term stories.

$STLA upgraded by Piper Sandler, trading at $10.91. Automotive production improvements and market share gains provide modest upside.

$TER upgraded by BofA, trading at $217.26. Exposure to semiconductor automation and AI-related infrastructure positions the company for incremental growth.

$TLX maintains Buy rating, trading at $7.56. Pipeline progress and clinical data will dictate near-term performance.

$VICR upgraded by Roth Capital, trading at $142.31. Power architecture leadership and AI adoption underpin growth potential.

$VOYA upgraded by Barclays to Overweight, trading at $78.75. Financial stability and investment yield support moderate upside.

$VZ continues to lead wireless adoption, trading at $40.46. 5G network growth and partnerships sustain steady revenue trajectory.

$WAB upgraded by Wolfe Research, trading at $224.42. Transport solutions and defense contracts provide a stable earnings base.

$YUM upgraded to Buy by Gordon Haskett, trading at $155.52. Global fast-food growth and franchise expansion drive long-term prospects.

$ZLAB initiated Buy by UBS, trading at $18.55. The biotech pipeline and expansion into global markets suggest upside potential if milestones are met.

View All Headlines